Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases (original) (raw)

References

  1. Aubourg P, Blanche S, Jambaque I, et al (1990) Reversal of early neurological and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 322:1860
    Google Scholar
  2. Baker RH, Trautman JC, Zimmerman D (1990) Late juvenile onset Krabbe’s disease. Ophthalmology 97:1176
    Google Scholar
  3. Bayever E, August CS, Kamani N, et al (1992) Allogeneic bone marrow transplanatation for Nieman-Pick Disease (Type IA). Bone Marrow Transplant 10 (Suppl 1):85
    Google Scholar
  4. Bezman I, Moser AB, Raymond GV, et al (2001) Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 29:512
    Google Scholar
  5. Biswas S, Levine SM (2002) Substrate-reduction therapy enhances the benefits of bone marrow transplantation in young mice with globoid cell leukodystrophy. Pediatr Res 51:40
    Google Scholar
  6. Braunlin EA, Hopwood JJ, Krivit W, et al (2001) Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in Hurler (MPS I-H). Am J Cardiol 88:1075
    Google Scholar
  7. Braunlin EA, Hopwood JJ, Krivit W, et al (2003) Usefulness of bone marrow transplantation in the Hurler syndrome. Am J Cardiol 93:882
    Google Scholar
  8. Cox TM, Lachmann R, Hollak C, et al (2000) Novel oral treatment of Gaucher’s disease with _N_-butyldeoxynojiumycin (OCT 918) to decrease substrate biosynthesis. Lancet 355:1401
    Google Scholar
  9. DeGasperi R, Krivit W, Kolodny EH, et al (1996) Molecular heterogeneity of late-onset form of globoid cell leukodystrophy. Am J Hum Genet 59:1233
    Google Scholar
  10. De Gasperi R, Raghavan SS, Krivit W, et al (2000) Measurements from normal umbilical cord blood of four lysosomal enzymatic activities: alpha-l-iduronidase (Hurler), galactocerebrosidase (globoid cell leukodsytrophy), arylsulfatase A (metachromatic leukodystrophy). Bone Marrow Transplant 25:541
    Google Scholar
  11. Ezoe T, Vanier M, Suzuki K, et al (2000) Twitcher mice with only a single active galactosylceramide synthase gene exhibit clearly detectable but therapeutically minor phenotype improvements. J Neurosci Res 59:179
    Google Scholar
  12. Gasper PW, Thrall MA, Wenger DA, et al 1984) Correction of feline arylsulfatase B deficiency (MPS VI) by bone marrow transplantation. Nature 311:467
    Google Scholar
  13. Grewal SS, Shapiro EG, Krivit W, et al (2004) Effective treatment of α-mannosidosis by allogeneic stem cell transplantation. J Pediatr 144:569–573
    Google Scholar
  14. Guffon N, Souillet G, Maire I, et al (1999) Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 133:119
    Google Scholar
  15. Guo AC, Petrella JR, Kurtzberg J, et al (2001) Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging. Initial experience. Radiology 215:809
    Google Scholar
  16. Hite S, Peters C, Krivit W (2000) Correction of odontoid dysplasia following bone marrow transplantation and engraftment in Hurler syndrome(MPSI-H). Pediatr Radiol 30:464
    Google Scholar
  17. Jacobson P, Prak JJ, Defor TE, et al (2001) Oral busulfan pharmacokinetics and engraftment in childen with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 27:855
    Google Scholar
  18. Keeling KM, Brooks DA, Hopwood JJ (2001) Gentamycin-mediated suppression of Hurler syndrome stop mutations restores a low level of α-l-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation. Hum Mol Genet 10:201
    Google Scholar
  19. Keene CD, Rodrigues, CM, Steer CJ, et al (2002) Taurodesoxycholiic acid, a bile acid, is neuroprotective in a transgeneic animal model of Huntingtons’s disease. Proc Natl Acad Sci USA 99:10671
    Google Scholar
  20. Krivit W (2002) Stem cell bone marrow transplantation in patients with metabolic storage diseases. Adv Pediatr 49:359
    Google Scholar
  21. Krivit W (2004) Metachromatic Leukodystrophy. In: Zimran E (ed) Glycolipid storage diseases. Adis International, Oxford 9:91–100
  22. Krivit W, Pierpont ME, Ayaz K, et al (1984) Bone marrow transplantation in the Maroteaux-Lamy syndrome(MPS VI). Biochemical and clinical status 24 months after transplantation. N Engl J Med 311:1606
    Google Scholar
  23. Krivit W, Freese D, Chan KW, Kulkarni R (1992) Wolman’s disease: a review of treatment with bone marrow transplantation and considerations for the future. Bone Marrow Transplant 10 (Suppl 1):97
    Google Scholar
  24. Krivit W, Shapiro EG, Peters C, et al (1998) Hematopoietic stem cell transplantation in globoid cell leukodystrophy: N Engl J Med 338:1119
    Google Scholar
  25. Krivit W, Peters C, Dusenbery K, et al (2000) Wolman disease successfully treated by bone marrow transplantation. Bone Marrow Transplant 26:567
    Google Scholar
  26. Krivit W, Kurtzberg J, Kolodny EH, et al (2004) Globoid cell leukodystrophy (Krabbe disease): study of normal umbilical cord blood galactocerebrosidase activity and polymorphic mutations. In: Abstracts of American Neurochemicl Socity Meeting, New York, 18 August
  27. Krivit W, Kurtzberg J, et al (2004) Proof of Principle: globoid cell leukodystrophy late-onset: effective therapeutic intervention in disease course by use of hematopoietic stem cell transplantation. In: Abstracts of the 149 Annual Meeting of Pediatric Academic Societies, San Francisco, 2 May 2004
  28. Lachman RH, Platt FM (2001) Substrate reduction therapy for sphingolipid storage disorders. Expert Opin Investig Drugs10:455
    Google Scholar
  29. Liu Y, Wada R, Kawa H (1999) A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest 102:497
    Google Scholar
  30. Li Y, Brockman K, Scott CR, et al (2004) Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for Krabbe disease. Clin Chem 50:638
    Google Scholar
  31. Maria BJ, Moser H, Naidu S, et al (2003 ) Leukodystrophies, pathogenesis, diagnosis, strategies, therapies and future directions. J Child Neurol 18:578
    Google Scholar
  32. Meilke PJ, Brooks DA, Hopwood J (1997) Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated-membrane protein (LAMP-1) as a diagnostic marker. Clin Chem 43:1325
    Google Scholar
  33. Meilke PJ, Hopwood JJ, Clague AE, et al (1999) Prevalence of lysosomal storage diseases. JAMA 281:249
    Google Scholar
  34. Moser HW, Loes DJ, Melham ER (2000) X-linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics 31:227
    Google Scholar
  35. Moser HW, Raymond GV, Koehler W, et al (2003) Evaluation of the preventive effect of glyceryl trioleate-trierucate (“Lorenzo’s Oil”) therapy in x-linked adrenoleukodystrophy: results of concurrent trials. Adv Exp Med Biol 544:369
    Google Scholar
  36. Peters C (2004) Hematopoietic stem cell transplantation for storage diseases. In: Blume KG, Forman SJ, Applebaum FR (eds) Hematopoietic stem cell transplantation, 3rd edn. Blackwell, Oxford, pp 1455–1470
  37. Peters C, Shapiro EG, Krivit W, et al (1998) Hurler: II. Outcome of HLA genotypically HLA-identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. Blood 91:2601
    Google Scholar
  38. Peters C, Krivit W (2000) Hematopoietic cell transplantation for MPS IIB (Hunter syndrome): an ethical commentary. Bone Marrow Transplant 25:1097
    Google Scholar
  39. Peters C, Krivit W, et al (2004) Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982–1999. Blood 104:881–888
    Google Scholar
  40. Richards K, Krivit W, Kurtzberg J, et al (2002) Correction of Krabbe disease with neonatal hematopoietic stem cell transplantation (Neurodevelopmental function and survival). In: Abstracts for the American Society for Blood and Marrow Transplantation, 22–26 February, Orlando, Florida
  41. Rose AG, Braunlin EA, Krivit W (2001) Cardiac disease in Hurler syndrome: an autopsy study of 14 patients including evidence that bone marrow transplantation prevents coronary arterial, myocardial and valvar disease. In: Lewis BA, Halen DA, et al (eds) Advances in Coronary Artery Disease. pp 695–700
  42. Shapiro EG, Lockman L, Krivit W (1991) Bone marrow transplantation as treatment for globoid cell leukodystrophy. In: Desnick RJ (ed) Treatment of genetic diseases. Churchill-Livingstone, New York, pp 222–238
  43. Shapiro EG, Lipton ME, Krivit W (1992) White matter dysfunction and its neuropsychological correlates: a longitudinal study of a case of metachromatic leukodystrophy treated with bone marrow transplantation. J Clin Exp Neuropsychol 14:610
    Google Scholar
  44. Shapiro EG, Krivit W, Lockman L, et al (2000) Long-term effect of bone marrow transplantation for childhood-onset cerebral X-linked adrenoleukodsytrophy. Lancet 356:713–718
    Google Scholar
  45. Staba SI, Krivit W, Kurtzberg J, et al (2004) Cord blood transplantation from unrelated donors in patients with Hurler syndrome. N Engl J Med 35:1960–1969
    Google Scholar
  46. Deleted
  47. Taylor RM, Farrow BRH, Stewart GI (1992) Amelioration of clinical disease following bone marrow transplantation in fucosidase deficient dogs. Am J Med Genet 42:628
    Google Scholar
  48. Tift CI, Proia RL (2000) Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases. Glycobology 10:1249
    Google Scholar
  49. Turner AT, Hopwood JJ, Brooks DA (2000) Enzyme replacement therapy in mucopolysaccharidosis I. Altered distribution and targeting of α-l-iduoinidase in immunized rats. Mol Genet Metab 69:277
    Google Scholar
  50. Van Geel BM, Bezman I, Loes DJ, et al (2001) Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol 49:186
    Google Scholar
  51. Vermoor J, Ehlert K, Bielacks S, et al (2002) Successful allogeneic stem cell transplantation in infantile ceramidase deficiency (Farber disease) type 2/3. Blood 100:4577
    Google Scholar
  52. Vinnalongan X, Sanz N, et al (1992) Hypertrophic cardiomyopathy in mucopolysaccharidosis: regression after bone marrow transplantation. Pediatr Cardiol 13:10
    Google Scholar
  53. Wall DA, Grangre DK, Gaulding P, et al (1998) Bone marrow transplantation for the treatment of α-mannosidosis. J Pediatr 133:282
    Google Scholar
  54. Sivakumar P, Wraith JE (1999) Bone marrow transplantation in mucopolysaccharidosis Type III A: A comparison of an early treated patient with his untreated sibling. Journal of Inherited Metabolic Disease 22:1849–1850
    Google Scholar
  55. Yeager AM, Uhai KA, Coles CD (2000) Bone marrow transplantation for infantile ceramidase deficiency (Farber disease). Bone Marrow Transplant 26:357
    Google Scholar

Download references